Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19

被引:23
作者
Dabrowska, Eliza [1 ]
Galinska-Skok, Beata [1 ]
Waszkiewicz, Napoleon [1 ]
机构
[1] Med Univ Bialystok, Dept Psychiat, Pl Brodowicza 1, PL-16070 Choroszcz, Poland
来源
LIFE-BASEL | 2021年 / 11卷 / 10期
关键词
COVID-19; SARS-CoV-2; neuroinflammation; depressive disorders; depression; neurocognitive disorders; post-covid; long-term; complications; ANGIOTENSIN-ALDOSTERONE SYSTEM; TRANSLOCATOR PROTEIN; MAJOR DEPRESSION; COGNITIVE FUNCTION; MENTAL-DISORDERS; DISEASE SEVERITY; HEALTH OUTCOMES; SURVIVORS; CYTOKINES; STRESS;
D O I
10.3390/life11101056
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dysfunctional effects of the coronavirus disease 2019 (COVID-19) infection on the nervous system are established. The manifestation of neuropsychiatric symptoms during and after infection is influenced by the neuroinvasive and neurotrophic properties of SARS-CoV-2 as well as strong inflammation characterised by a specific "cytokine storm ". Research suggests that a strong immune response to a SARS-CoV-2 infection and psychological stressors related to the pandemic may cause chronic inflammatory processes in the body with elevated levels of inflammatory markers contributing to the intensification of neurodegenerative processes. It is suggested that neuroinflammation and associated central nervous system changes may significantly contribute to the etiopathogenesis of depressive disorders. In addition, symptoms after a COVID-19 infection may persist for up to several weeks after an acute infection as a post-COVID-19 syndrome. Moreover, previous knowledge indicates that among SSRI (selective serotonin reuptake inhibitor) group antidepressants, fluoxetine is a promising drug against COVID-19. In conclusion, further research, observation and broadening of the knowledge of the pathomechanism of a SARS-CoV-2 infection and the impact on potential complications are necessary. It is essential to continue research in order to assess the long-term neuropsychiatric effects in COVID-19 patients and to find new therapeutic strategies.</p>
引用
收藏
页数:25
相关论文
共 224 条
[1]   THE IMMUNE-SYSTEM AND THE NERVOUS-SYSTEM [J].
AARLI, JA .
JOURNAL OF NEUROLOGY, 1983, 229 (03) :137-154
[2]   Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study [J].
Abbasi, Seyed-Hesameddin ;
Hosseini, Fahimeh ;
Modabbernia, Amirhossein ;
Ashrafi, Mandana ;
Akhondzadeh, Shahin .
JOURNAL OF AFFECTIVE DISORDERS, 2012, 141 (2-3) :308-314
[3]   Fear of COVID-19 and stigmatization towards infected people among Jordanian people [J].
Abuhammad, Sawsan ;
Alzoubi, Karem ;
Khabour, Omar .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
[4]   The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis [J].
Akbari, Hamed ;
Tabrizi, Reza ;
Lankarani, Kamran B. ;
Aria, Hamid ;
Vakili, Sina ;
Asadian, Fatemeh ;
Noroozi, Saam ;
Keshavarz, Pedram ;
Faramarz, Sanaz .
LIFE SCIENCES, 2020, 258
[5]   COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience [J].
Alemanno, Federica ;
Houdayer, Elise ;
Parma, Anna ;
Spina, Alfio ;
Del Forno, Alessandra ;
Scatolini, Alessandra ;
Angelone, Sara ;
Brugliera, Luigia ;
Tettamanti, Andrea ;
Beretta, Luigi ;
Iannaccone, Sandro .
PLOS ONE, 2021, 16 (02)
[6]   Burnout and depression among psychiatry residents during COVID-19 pandemic [J].
Alkhamees, Abdulmajeed A. ;
Assiri, Hatem ;
Alharbi, Hatim Yousef ;
Nasser, Abdullah ;
Alkhamees, Mohammad A. .
HUMAN RESOURCES FOR HEALTH, 2021, 19 (01)
[7]   Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines -two case reports [J].
Alpert, Orna ;
Begun, Leonid ;
Garren, Patrik ;
Solhkhah, Ramon .
BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2020, 9
[8]  
Alster Olga, 2014, Postepy Biochem, V60, P138
[9]   Postacute COVID-19: An Overview and Approach to Classification [J].
Amenta, Eva M. ;
Spallone, Amy ;
Rodriguez-Barradas, Maria C. ;
El Sahly, Hana M. ;
Atmar, Robert L. ;
Kulkarni, Prathit A. .
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12)
[10]   The renin-angiotensin-aldosterone system and its suppression [J].
Ames, Marisa K. ;
Atkins, Clarke E. ;
Pitt, Bertram .
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2019, 33 (02) :363-382